Literature DB >> 2902333

Ciprofloxacin and tenosynovitis.

S R McEwan, P G Davey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2902333     DOI： 10.1016/s0140-6736(88)92489-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Fluoroquinolones and risk of Achilles tendon disorders: case-control study.

Authors:  P D van der Linden; M C J M Sturkenboom; R M C Herings; H G M Leufkens; B H Ch Stricker
Journal:  BMJ       Date:  2002-06-01

Review 2.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

3.  Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study.

Authors:  Giovanni Corrao; Antonella Zambon; Lorenza Bertù; Anna Mauri; Valentina Paleari; Camillo Rossi; Mauro Venegoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 5.  Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature.

Authors:  Trevor Lewis; Jill Cook
Journal:  J Athl Train       Date:  2014-04-24       Impact factor: 2.860

6.  Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds.

Authors:  Y Kashida; M Kato
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 7.  Safety Concerns Surrounding Quinolone Use in Children.

Authors:  Karisma Patel; Jennifer L Goldman
Journal:  J Clin Pharmacol       Date:  2016-03-28       Impact factor: 3.126

Review 8.  [Cartilage-damaging effect of quinolones].

Authors:  R Stahlmann
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 9.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

10.  A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.

Authors:  X Chevalier; E Albengres; M C Voisin; J P Tillement; B Larget-Piet
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.